FIELD: pharmaceuticals.
SUBSTANCE: invention relates to piperidine urea derivatives, Claim 1, and to their pharmaceutically acceptable salts. Invention also relates to drugs which inhibit the activity of Tankyrases (TANKs) and poly(ADP-ribose)polymerase PARP-1, based on these compounds.
EFFECT: new compounds have been obtained that can be used in medicine for the treatment of diseases such as malignant neoplasm, cardiovascular diseases, central nervous system lesions and various forms of inflammation.
2 cl, 3 tbl, 37 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OXOQUINAZOLINYL-BUTANAMIDE DERIVATIVES | 2014 |
|
RU2669393C2 |
| 3-AMINOCYCLOPENTANCARBOXAMIDE DERIVATIVES | 2013 |
|
RU2641913C2 |
| QUINAZOLINONE DERIVATIVES AS PARP INHIBITORS | 2013 |
|
RU2650107C2 |
| DISCLOSED ARE 3,6-DIAMINOPYRIDAZIN-3-YL DERIVATIVES CONTAINING PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS PRO-APOPTOTIC AGENTS | 2020 |
|
RU2830186C2 |
| DISCLOSED ARE 6,7-DIHYDRO-5H-PYRIDO[2,3-C]PYRIDAZINE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF BCLXL PROTEINS AND PROAPOPTOTIC AGENTS FOR TREATING MALIGNANT NEOPLASMS | 2020 |
|
RU2832191C2 |
| BENZOXAZEPINE PI3 INHIBITORS AND METHODS OF USE | 2010 |
|
RU2654068C1 |
| TLR7/8 ANTAGONISTS AND THEIR APPLICATION | 2017 |
|
RU2758686C2 |
| DERIVATIVES OF INDOLIN-2-SHE AS INHIBITORS OF PROTEINKINAS | 2013 |
|
RU2627706C2 |
| QUINOLINE-2 DERIVATIVES AS C-KIT KINASE INHIBITORS | 2016 |
|
RU2754858C2 |
| 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES | 2020 |
|
RU2822388C2 |
